{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:38:24Z","timestamp":1788057504483,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ijrobp.2012.03.025","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T11:21:19Z","timestamp":1345202479000},"page":"40-46","source":"Crossref","is-referenced-by-count":37,"title":["A Prospective, Multicenter Study of Complementary\/Alternative Medicine (CAM) Utilization During Definitive Radiation for Breast Cancer"],"prefix":"10.1016","volume":"85","author":[{"given":"Meena S.","family":"Moran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangge","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Jagsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-I Jonathan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne B.","family":"Weidhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn D.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Peschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant","family":"Gaudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2012.03.025_bib1","first-page":"66","article-title":"Integrative oncology practice guidelines","volume":"5","author":"Deng","year":"2007","journal-title":"J Soc Integr Oncol"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib2","unstructured":"National Institute of Health. What is complementary and alternative medicine? Available at: http:\/\/nccam.nih.gov\/health\/whatiscam\/. Accessed April 1,\u00a02012."},{"key":"10.1016\/j.ijrobp.2012.03.025_bib3","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.ejca.2006.02.019","article-title":"The role of complementary and alternative medicine in the management of early-stage breast cancer: Recommendations of the European Society of Mastology (EUSOMA)","volume":"42","author":"Baum","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9610(00)00358-5","article-title":"A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites","volume":"179","author":"Morris","year":"2000","journal-title":"Am J Surg"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199906033402206","article-title":"Use of alternative medicine by women with early-stage breast cancer","volume":"340","author":"Burstein","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/jnci\/92.1.42","article-title":"Alternative therapies used by women with breast cancer in four ethnic populations","volume":"92","author":"Lee","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00520-002-0356-1","article-title":"Use of complementary and alternative medicine by breast cancer patients: Prevalence, patterns and communication with physicians","volume":"10","author":"Ashikaga","year":"2002","journal-title":"Supportive Care in Cancer: J\u00a0Multinational Assoc Supportive Care in Cancer"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1188\/03.ONF.811-821","article-title":"Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer","volume":"30","author":"Lengacher","year":"2003","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/acm.2006.12.459","article-title":"Levels of commitment: Exploring complementary therapy use by women with breast cancer","volume":"12","author":"Balneaves","year":"2006","journal-title":"J\u00a0Altern Complement Med"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1089\/acm.2008.0039","article-title":"The use of complementary and alternative medicine among Chinese women with breast cancer","volume":"14","author":"Chen","year":"2008","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/94.1.39","article-title":"Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study","volume":"94","author":"Ganz","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6874-7-4","article-title":"Trends in complementary\/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005","volume":"7","author":"Boon","year":"2007","journal-title":"BMC Women's Health"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/NNR.0b013e3181c3bd26","article-title":"Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer","volume":"59","author":"Wyatt","year":"2010","journal-title":"Nurs Res"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00520-010-0846-5","article-title":"Complementary and alternative medicine: Use and disclosure in radiation oncology community practice","volume":"19","author":"Rausch","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10549-004-3779-1","article-title":"Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death","volume":"90","author":"Rakovitch","year":"2005","journal-title":"Breast Cancer Res Treatment"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2288-6-56","article-title":"Checklist for the qualitative evaluation of clinical studies with particular focus on external validity and model validity","volume":"6","author":"Bornhoft","year":"2006","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2753.2000.00263.x","article-title":"Questionnaire surveys in medical research","volume":"6","author":"Mandal","year":"2000","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1472-6882-11-30","article-title":"Complementary and alternative medicine use among breast cancer survivors: The Black Women's Health Study","volume":"11","author":"Bright-Gbebry","year":"2011","journal-title":"BMC Compl Alternative Med"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib20","first-page":"34S","article-title":"Complementary and alternative medicine use among women with breast cancer","volume":"20","author":"DiGianni","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib21","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2004.04.162","article-title":"An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies","volume":"22","author":"Navo","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J077v23n04_03","article-title":"Patient-physician communication regarding use of complementary therapies during cancer treatment","volume":"23","author":"Roberts","year":"2005","journal-title":"J\u00a0Psychosoc Oncol"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jnci\/djn148","article-title":"Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?","volume":"100","author":"Lawenda","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2012.03.025_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10549-004-4260-x","article-title":"Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh","volume":"90","author":"Rockwell","year":"2005","journal-title":"Breast Cancer Res Treat"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301612004208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301612004208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T06:55:23Z","timestamp":1542783323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301612004208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0360301612004208"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2012.03.025","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}